License AmendmentLicense Amendment • August 23rd, 2006 • Neopharm Inc • Biological products, (no disgnostic substances)
WHEREAS, the National Institutes of Health (“NIH”), on behalf of the Public Health Service (“PHS”) and the Department of Health and Human Services (“DHHS”), and NeoPharm, Inc. (“Licensee”) entered into license agreement (L-024-2006/0; the “Agreement”) effective May 30, 2006 under which HHS Ref. E-173-1992/0 corresponding to US. Patent 5,720,720; entitled “Convection-Enhanced Drug Delivery,” was licensed nonexclusively to be used for the administration of therapeutics to the central nervous system, including IL-13PE:38QQR compounds and compositions.
